Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Dec;62(6):947–953. doi: 10.1038/bjc.1990.415

Cisplatin and CCNU synergism in spheroid cell subpopulations.

R E Durand 1
PMCID: PMC1971572  PMID: 2257225

Abstract

The cytotoxicity of two antineoplastic drugs, cisplatin and CCNU, was evaluated in Chinese hamster V79 multicell spheroids using the drugs as single agents or combinations. Cells obtained from different depths within spheroids 550-750 microns in diameter showed different sensitivities to the two agents; the external cells of the spheroids were more sensitive than the internal cells to cisplatin, whereas the internal cells were most effectively killed by CCNU. Combining the two agents produced the expected 'complementary' activity, and in addition, synergism was observed between the drugs at exposure levels practical for clinical use. For the combination treatments, both the net pattern of cell killing through the spheroid and the degree of interaction between the agents (quantified using the combination index method) were a function of the dose ratio of the two drugs, and of overall treatment intensity. BCNU produced patterns of cell killing similar to CCNU, but showed little interaction with cisplatin. Our results suggest significant clinical potential in using CCNU with cisplatin, particularly since CCNU-cisplatin combinations were synergistic even in the cell subpopulations most resistant to each drug as a single agent.

Full text

PDF
947

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chou T. C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55. doi: 10.1016/0065-2571(84)90007-4. [DOI] [PubMed] [Google Scholar]
  2. Day R. S., 3rd, Babich M. A., Yarosh D. B., Scudiero D. A. The role of O6-methylguanine in human cell killing, sister chromatid exchange induction and mutagenesis: a review. J Cell Sci Suppl. 1987;6:333–353. doi: 10.1242/jcs.1984.supplement_6.22. [DOI] [PubMed] [Google Scholar]
  3. Day R. S., 3rd, Ziolkowski C. H., Scudiero D. A., Meyer S. A., Lubiniecki A. S., Girardi A. J., Galloway S. M., Bynum G. D. Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature. 1980 Dec 25;288(5792):724–727. doi: 10.1038/288724a0. [DOI] [PubMed] [Google Scholar]
  4. Durand R. E. Cell cycle kinetics in an in vitro tumor model. Cell Tissue Kinet. 1976 Sep;9(5):403–412. doi: 10.1111/j.1365-2184.1976.tb01290.x. [DOI] [PubMed] [Google Scholar]
  5. Durand R. E. Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment. J Natl Cancer Inst. 1986 Jul;77(1):247–252. [PubMed] [Google Scholar]
  6. Durand R. E. Distribution and activity of antineoplastic drugs in a tumor model. J Natl Cancer Inst. 1989 Jan 18;81(2):146–152. doi: 10.1093/jnci/81.2.146. [DOI] [PubMed] [Google Scholar]
  7. Durand R. E., Goldie J. H. Interaction of etoposide and cisplatin in an in vitro tumor model. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):673–679. [PubMed] [Google Scholar]
  8. Durand R. E. Use of a cell sorter for assays of cell clonogenicity. Cancer Res. 1986 Jun;46(6):2775–2778. [PubMed] [Google Scholar]
  9. Mitchell E. P., Schein P. S. Contributions of nitrosoureas to cancer treatment. Cancer Treat Rep. 1986 Jan;70(1):31–41. [PubMed] [Google Scholar]
  10. Mulcahy R. T., Gipp J. J., Tanner M. A. Sensitization of nitrosourea-resistant Mer+ human tumor cells to N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea by mild (41 degrees C) hyperthermia. Cancer Res. 1988 Mar 1;48(5):1086–1090. [PubMed] [Google Scholar]
  11. Nederman T., Carlsson J., Malmqvist M. Penetration of substances into tumor tissue--a methodological study on cellular spheroids. In Vitro. 1981 Apr;17(4):290–298. doi: 10.1007/BF02618140. [DOI] [PubMed] [Google Scholar]
  12. Olive P. L., Leonard J. C., Durand R. E. Development of tetraploidy in V79 spheroids. In Vitro. 1982 Aug;18(8):708–714. doi: 10.1007/BF02796426. [DOI] [PubMed] [Google Scholar]
  13. Prestayko A. W., D'Aoust J. C., Issell B. F., Crooke S. T. Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev. 1979 Mar;6(1):17–39. doi: 10.1016/s0305-7372(79)80057-2. [DOI] [PubMed] [Google Scholar]
  14. Rice G. C., Hoy C., Schimke R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci U S A. 1986 Aug;83(16):5978–5982. doi: 10.1073/pnas.83.16.5978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Corbett T. H., Griswold D. P., Jr cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459–1473. [PubMed] [Google Scholar]
  16. Steel G. G., Peckham M. J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):85–91. doi: 10.1016/0360-3016(79)90044-0. [DOI] [PubMed] [Google Scholar]
  17. Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988 Apr 8;240(4849):177–184. doi: 10.1126/science.2451290. [DOI] [PubMed] [Google Scholar]
  18. Sutherland R. M., Durand R. E. Radiation response of multicell spheroids--an in vitro tumour model. Curr Top Radiat Res Q. 1976 Jan;11(1):87–139. [PubMed] [Google Scholar]
  19. Young S. D., Marshall R. S., Hill R. P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9533–9537. doi: 10.1073/pnas.85.24.9533. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES